DaVita Inc
DVA: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| v$w | LOCK|m?^X | LOCK|FGzlZf |
DaVita Earnings: Keeps 2025 Guidance Roughly Intact Despite Ongoing Volume and Margin Challenges
In the third quarter, dialysis service provider DaVita grew revenue by 5%, but its adjusted EPS declined 3% year over year, despite major share repurchase activities in recent months. The company kept its 2025 roughly guidance intact, though, just narrowing some ranges.
